NIH PAR · NIGMS · P30

PAR-27-054: Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards

Open for applicationsNext due date: Jan 25, 2027Expires May 27, 2029

The Institutional Development Awards (IDeA) program supports biomedical research capacity building in states that have historically received low levels of NIH funding. The Centers of Biomedical Research Excellence: Development Phase (COBRE-D) program supports institutions in IDeA states to increase their biomedical research capacity in a broad scientific area of strategic importance to them but for which they have limited existing infrastructure or expertise.COBRE-D supports a long-term institutional vision focused on the recruitment and mentoring of early-career investigators with supplemental start-up packages for new hires, the establishment of research facilities, and enhancement of…

Full NOFO in the NIH Guide Apply on Grants.gov

NOFO number
PAR-27-054
Type
PAR
Activity code
P30
Primary institute
NIGMS · National Institute of General Medical Sciences
Clinical trials
Not Allowed
Posted
Aug 19, 2026
Opens
Aug 25, 2026
Expires
May 27, 2029

PAR-27-054 due dates

8 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.

Application due dates and review cycles for PAR-27-054
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
September 25, 2026 *September 25, 2026 *Not ApplicableMarch 2027May 2027July 2027
January 25, 2027 *January 25, 2027 *Not ApplicableJuly 2027October 2027December 2027
May 25, 2027 *May 25, 2027 *Not ApplicableNovember 2027January 2028April 2028
September 25, 2027 *September 25, 2027 *Not ApplicableMarch 2028May 2028July 2028
January 25, 2028 *January 25, 2028 *Not ApplicableJuly 2028October 2028December 2028
May 25, 2028 *May 25, 2028 *Not ApplicableNovember 2028January 2029April 2029
September 25, 2028 *September 25, 2028 *Not ApplicableMarch 2029May 2029July 2029
January 25, 2029 *January 25, 2029 *Not ApplicableJuly 2029October 2029December 2029
May 25, 2029 *May 25, 2029 *Not ApplicableNovember 2029January 2030April 2030

What its predecessor PAR-22-250 funded

PAR-27-054 reissues PAR-22-250. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 27 projects and $133.1M in FY2022–FY2026.

Projects funded

27

Distinct projects, FY2022–FY2026

New awards

27

Type 1 (new project) award records

NIH funding

$133.1M

Award dollars under PAR-22-250, FY2022–FY2026

Funding by fiscal year

Award records, new awards, and funding by fiscal year under PAR-22-250
Fiscal yearAward recordsNew awardsFunding
FY202200$0
FY202300$0
FY20241010$23.4M
FY20252010$47.0M
FY2026277$62.6M

Institutions with the most funding

  1. Univ of Arkansas for Med Scis$11.8M · 2 projects
  2. Mc Laughlin Research Institute$8.4M · 1 project
  3. University of Nebraska Medical Center$7.2M · 1 project
  4. University of Kansas Lawrence$7.2M · 1 project
  5. University of Idaho$6.7M · 1 project
  6. Tulane University of Louisiana$6.7M · 1 project
  7. University of New England$6.6M · 1 project
  8. Oklahoma State University Stillwater$6.6M · 1 project

Funding institutes

  • NIGMS$133.1M · 57

Activity codes funded

  • P2057 records

Most recent new awards

FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.

Participating institutes

2 NIH institutes and offices take applications under PAR-27-054. Contact the program officer at the institute that fits your research before applying.

  • NIGMS · National Institute of General Medical Sciences
  • none

Related notices

  1. Jan 23, 2026 · NOT-OD-26-031

    NIH Pause on New Submissions to the NIH Human Embryonic Stem Cell Registry and Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research.

Award terms

Application types allowed
New Revision The OER Glossary and the How to Apply - Application Guide provides details on these application types. Only those application types listed here are allowed for this NOFO.
Award budget
Application budgets are limited to 400,000 direct costs during year 1 and 1.8 million in annual direct costs in years 2-5.
Project period
The project period is limited to five years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
Funds available and number of awards
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.

Related NOFOs

  • Reissue of PAR-22-250.

Other open NOFOs for P30

Browse all open NIH NOFOs

About this page

GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.

Find who wins under this NOFO

NIH grant searchLook up awards by topic, PI, or institution.Find funded PIsInvestigators with recent NIH awards in your research area.Institute fit by topicWhich NIH institutes and institutions lead a research area.Funding trendsYear-by-year NIH award totals for any keyword.